These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29330810)

  • 1. Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging.
    Karsy M; Gillespie DL; Horn KP; Burrell LD; Yap JT; Jensen RL
    Methods Mol Biol; 2018; 1742():301-320. PubMed ID: 29330810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using [¹⁸F]FBAU for imaging brain tumor progression in an F98/tk-luc glioma-bearing rat model.
    Chien YC; Chen JC; Lin WC; Ding HJ; Wang HE; Kao CH; Hwang JJ
    Oncol Rep; 2014 Aug; 32(2):691-9. PubMed ID: 24926696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
    Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD
    Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.
    Valable S; Corroyer-Dulmont A; Chakhoyan A; Durand L; Toutain J; Divoux D; Barré L; MacKenzie ET; Petit E; Bernaudin M; Touzani O; Barbier EL
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2584-2597. PubMed ID: 27702880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
    Cher LM; Murone C; Lawrentschuk N; Ramdave S; Papenfuss A; Hannah A; O'Keefe GJ; Sachinidis JI; Berlangieri SU; Fabinyi G; Scott AM
    J Nucl Med; 2006 Mar; 47(3):410-8. PubMed ID: 16513609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of O-(2-
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.
    Mathieu D; Lecomte R; Tsanaclis AM; Larouche A; Fortin D
    Can J Neurol Sci; 2007 Aug; 34(3):296-306. PubMed ID: 17803026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
    Chen YR; Li WX; Lin YR; Chen LH
    Ai Zheng; 2004 Oct; 23(10):1210-2. PubMed ID: 15473938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.
    Verburg N; Pouwels PJ; Boellaard R; Barkhof F; Hoekstra OS; Reijneveld JC; Vandertop WP; Wesseling P; de Witt Hamer PC
    Neurosurgery; 2016 Oct; 79(4):535-40. PubMed ID: 27479710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.
    Lo Dico A; Valtorta S; Martelli C; Belloli S; Gianelli U; Tosi D; Bosari S; Degrassi A; Russo M; Raccagni I; Lucignani G; Moresco RM; Ottobrini L
    Mol Imaging Biol; 2014 Apr; 16(2):210-23. PubMed ID: 24002614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
    Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
    Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma.
    Mapelli P; Picchio M
    Int J Biol Markers; 2020 Feb; 35(1_suppl):42-46. PubMed ID: 32079461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IIa clinical study of [
    Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
    Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.